Cargando…

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone

Women show greater pathological Tau biomarkers than men along the Alzheimer’s disease (AD) continuum, particularly among apolipoprotein ε-E4 (APOE4) carriers; however, the reason for this sex difference in unknown. Sex differences often indicate an underlying role of sex hormones. We examined whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundermann, Erin E., Panizzon, Matthew S., Chen, Xu, Andrews, Murray, Galasko, Douglas, Banks, Sarah J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304096/ https://www.ncbi.nlm.nih.gov/pubmed/32560743 http://dx.doi.org/10.1186/s13293-020-00310-x

Ejemplares similares

The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
por: Bernier, Rachel A., et al.
Publicado: (2022)

Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
por: Galasko, Douglas
Publicado: (2015)

Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
por: Andrews, Murray, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry
por: Blennow, Kaj, et al.
Publicado: (2000)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Sex-specific composite scales for longitudinal studies of incipient Alzheimer’s disease
por: Banks, Sarah J., et al.
Publicado: (2019)

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
por: Galasko, Douglas, et al.
Publicado: (2013)

Associations Between Parity and Cognition: Race/Ethnic Differences
por: Araujo-Menendez, Carlos E.E., et al.
Publicado: (2023)

Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Sex differences in vascular aging in response to testosterone
por: Moreau, Kerrie L., et al.
Publicado: (2020)

Sex Differences in Migraine: A Twin Study
por: Fitzgerald, Morgan C., et al.
Publicado: (2021)

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
por: Gonzalez-Ortiz, Fernando, et al.
Publicado: (2022)

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
por: Ossenkoppele, Rik, et al.
Publicado: (2021)

Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
por: Thomas, Kelsey R., et al.
Publicado: (2021)

The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men
por: Hauger, Richard L., et al.
Publicado: (2022)

Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markers
por: Sundermann, Erin E., et al.
Publicado: (2018)

(18)F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Sex Differences in the Association Between Testosterone and Violent Behaviors
por: Assari, Shervin, et al.
Publicado: (2014)

Identification of Sex-Specific Genetic Variants Associated With Tau PET
por: Wang, Xin, et al.
Publicado: (2022)

Sex-Differences in Traumatic Brain Injury in the Absence of Tau in Drosophila
por: Shah, Ekta J., et al.
Publicado: (2021)

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
por: Smirnov, Denis S., et al.
Publicado: (2022)

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
por: Sundermann, Erin E., et al.
Publicado: (2023)

Recent Alzheimer's disease research highlights
por: Galasko, Douglas, et al.
Publicado: (2012)

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
por: Galasko, Douglas, et al.
Publicado: (2020)

CSF P-tau 231 as Biomarker in Alzheimer's Disease
por: Mukherjee, Adreesh, et al.
Publicado: (2022)

Prenatal testosterone does not explain sex differences in spatial ability
por: Toivainen, Teemu, et al.
Publicado: (2018)

Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
por: Handelsman, David J, et al.
Publicado: (2018)

Impact of Testosterone on Alzheimer’s Disease
por: Bianchi, Vittorio Emanuele
Publicado: (2022)

Right sizing funding for Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2011)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Tau-mediated synaptic damage in Alzheimer’s disease
por: Jadhav, Santosh, et al.
Publicado: (2015)

Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone–binding globulin, and hypertension
por: Yang, Qingtao, et al.
Publicado: (2019)

Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
por: Coughlin, David G., et al.
Publicado: (2022)

Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases
por: Manca, Matteo, et al.
Publicado: (2023)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

LONELINESS IS INVERSELY ASSOCIATED WITH EXERCISE AND SLEEP APNEA IN OLDER WOMEN AT RISK FOR ALZHEIMER’S DISEASE
por: Danish, Madina, et al.
Publicado: (2022)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
por: Meredith Jr., Jere E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_596mhavu42qk6km806oode2gto